Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HER2+ predictive biomarkers

Giampaolo Bianchini

詹帕洛·比安基尼

MD

🏢IRCCS Ospedale San Raffaele(IRCCS圣拉斐尔医院)🌐Italy

Head of Breast Oncology乳腺肿瘤科主任

50
h-index
1
Key Papers
1
Awards
2
Key Contributions

👥Biography 个人简介

Giampaolo Bianchini at San Raffaele Hospital in Milan is a leading European expert in HER2+ breast cancer biology and translational research. His work on molecular mechanisms of response and resistance to HER2-targeted therapy has identified predictive biomarkers and rational combination strategies.

Share:

🧪Research Fields 研究领域

HER2-positive breast cancerHER2阳性乳腺癌
tumor biology肿瘤生物学
translational research转化研究
predictive biomarkers预测性生物标志物
neoadjuvant therapy新辅助治疗

🎓Key Contributions 主要贡献

HER2+ Breast Cancer Biomarkers

Identified molecular signatures predicting response to dual HER2 blockade in neoadjuvant setting, enabling personalized escalation and de-escalation strategies.

PI3K Resistance Mechanisms

Characterized PI3K pathway alterations as drivers of resistance to HER2 inhibition and identified rational combination strategies.

Representative Works 代表性著作

[1]

Pertuzumab and trastuzumab in patients with locally advanced HER2-positive breast cancer

Nature Reviews Clinical Oncology (2019)

Review of dual HER2 blockade mechanisms and resistance.

🏆Awards & Recognition 奖项与荣誉

🏆ESMO Young Oncologist Award

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 詹帕洛·比安基尼 的研究动态

Follow Giampaolo Bianchini's research updates

留下邮箱,当我们发布与 Giampaolo Bianchini(IRCCS Ospedale San Raffaele)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment